Zelinkova Z - Search Results

1

Maternal imprinting and female predominance in familial Crohn's disease.

Zelinkova Z, Stokkers PC, van der Linde K, Kuipers EJ, Peppelenbosch MP, van der Woude CP. Zelinkova Z, et al. J Crohns Colitis. 2012 Aug;6(7):771-6. doi: 10.1016/j.crohns.2012.01.002. Epub 2012 Jan 23. J Crohns Colitis. 2012. PMID: 22398090

2

Impact of double-balloon enteroscopy findings on the management of Crohn's disease.

Mensink PB, Aktas H, Zelinkova Z, West RL, Kuipers EJ, van der Woude CJ. Mensink PB, et al. Among authors: zelinkova z. Scand J Gastroenterol. 2010 Apr;45(4):483-9. doi: 10.3109/00365520903563774. Scand J Gastroenterol. 2010. PMID: 20059403

3

Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.

Hommes DW, Duijvestein M, Zelinkova Z, Stokkers PC, Ley MH, Stoker J, Voermans C, van Oers MH, Kersten MJ. Hommes DW, et al. Among authors: zelinkova z. J Crohns Colitis. 2011 Dec;5(6):543-9. doi: 10.1016/j.crohns.2011.05.004. Epub 2011 Jun 12. J Crohns Colitis. 2011. PMID: 22115372

4

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease.

West RL, Zelinkova Z, Wolbink GJ, Kuipers EJ, Stokkers PC, van der Woude CJ. West RL, et al. Among authors: zelinkova z. Aliment Pharmacol Ther. 2008 Nov 1;28(9):1122-6. doi: 10.1111/j.1365-2036.2008.03828.x. Epub 2008 Aug 8. Aliment Pharmacol Ther. 2008. PMID: 18691349 Free article.

5

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.

Zelinkova Z, de Haar C, de Ridder L, Pierik MJ, Kuipers EJ, Peppelenbosch MP, van der Woude CJ. Zelinkova Z, et al. Aliment Pharmacol Ther. 2011 May;33(9):1053-8. doi: 10.1111/j.1365-2036.2011.04617.x. Epub 2011 Mar 1. Aliment Pharmacol Ther. 2011. PMID: 21366638 Free article.

6

Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment.

Lie MR, Peppelenbosch MP, West RL, Zelinkova Z, van der Woude CJ. Lie MR, et al. Among authors: zelinkova z. Aliment Pharmacol Ther. 2014 Nov;40(10):1202-8. doi: 10.1111/apt.12969. Epub 2014 Sep 28. Aliment Pharmacol Ther. 2014. PMID: 25263077 Free article.

7

Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases.

Zelinkova Z, Mensink PB, Dees J, Kuipers EJ, van der Woude CJ. Zelinkova Z, et al. Scand J Gastroenterol. 2010;45(1):46-50. doi: 10.3109/00365520903362628. Scand J Gastroenterol. 2010. PMID: 19883275

8

Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.

Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, van der Woude CJ. Zelinkova Z, et al. World J Gastroenterol. 2012 Dec 21;18(47):6967-73. doi: 10.3748/wjg.v18.i47.6967. World J Gastroenterol. 2012. PMID: 23322995 Free PMC article.

9

High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study.

Baars JE, Zelinkova Z, Mensink PB, Markus T, Looman CW, Kuipers EJ, Van Der Woude CJ. Baars JE, et al. Among authors: zelinkova z. Aliment Pharmacol Ther. 2009 Oct 15;30(8):864-72. doi: 10.1111/j.1365-2036.2009.04103.x. Epub 2008 Jul 23. Aliment Pharmacol Ther. 2009. PMID: 19706149 Free article.

10

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients.

Bultman E, de Haar C, van Liere-Baron A, Verhoog H, West RL, Kuipers EJ, Zelinkova Z, van der Woude CJ. Bultman E, et al. Among authors: zelinkova z. Aliment Pharmacol Ther. 2012 Feb;35(3):335-41. doi: 10.1111/j.1365-2036.2011.04946.x. Epub 2011 Dec 22. Aliment Pharmacol Ther. 2012. PMID: 22191671 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page